Table 3.
KIF1A Expression Associated with Clinicopathologic Characteristics (Logistic Regression)
| Characteristics | Total (N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| FIGO stage (Stage III & Stage IV vs Stage I & Stage II) | 376 | 0.308 (0.109–0.753) | 0.015 |
| Primary therapy outcome (CR vs PD&SD&PR) | 308 | 0.836 (0.512–1.362) | 0.471 |
| Race (White & Black or African American vs Asian) | 365 | 0.727 (0.212–2.319) | 0.591 |
| Age (>60 vs ≤60) | 379 | 1.621 (1.080–2.442) | 0.020 |
| Histologic grade (G3 vs G2) | 369 | 0.845 (0.451–1.569) | 0.486 |
| Venous invasion (Yes vs No) | 105 | 0.565 (0.251–1.244) | 0.160 |
| Anatomic neoplasm subdivision (Bilateral vs Unilateral) | 357 | 0.962 (0.607–1.523) | 0.867 |
| Lymphatic invasion (Yes vs No) | 149 | 0.522 (0.255–1.047) | 0.070 |
| Tumor residual (RD vs NRD) | 335 | 0.752 (0.437–1.286) | 0.300 |
| Tumor status (With tumor vs Tumor free) | 337 | 0.849 (0.502–1.430) | 0.538 |